Protein movement during complex-formation between tissue plasminogen activator and plasminogen activator inhibitor-1.
Plasminogen activator inhibitor-1 (PAI-1) rapidly inactivates tissue plasminogen activator (tPA). After initial binding and cleavage of the reactive-centre loop of PAI-1, this complex is believed to undergo a major rearrangement. Using surface plasmon resonance and SDS-PAGE, we have studied the influence of a panel of monoclonal antibodies on the reaction leading to the final covalent complex. On the basis of these data, we suggest the mechanisms for the action of different classes of inhibitory antibodies. We propose that the antibodies which convert PAI-1 into a substrate for tPA do this by means of preventing the conversion of the initial PAI-1/tPA complex into the final complex by sterical intervention. Moreover, the localisation of the binding epitopes on free PAI-1, as well as on the PAI-1/tPA complex, suggests that tPA in the final complex cannot be located near helices E and F, as has previously been proposed.
Björquist
P
P
Department of Cell Biology and Biochemistry, Preclinical Research and Development, Astra Hässle AB, S-431 83, Mölndal, Sweden. johanna.deinum@hassle.se.astra.com
Ehnebom
J
J
Deinum
J
J
D000911:Antibodies, Monoclonal / Q000737:chemistry; D000939:Epitopes / Q000737:chemistry; D017395:Plasminogen Activator Inhibitor 1 / Q000737:chemistry* / Q000276:immunology; D011487:Protein Conformation; D020349:Surface Plasmon Resonance; D010959:Tissue Plasminogen Activator / Q000737:chemistry*
D000911:Antibodies, Monoclonal; D000939:Epitopes; D017395:Plasminogen Activator Inhibitor 1; D010959:Tissue Plasminogen Activator